Novo seeks $830M in fraud case against Singaporean biotech over kidney drug
Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline
Medtronic's diabetes device sales drive profit beat but surgical unit lags
First biosimilar fast-acting insulin reaches US market
*please scroll down for all the latest news*
